RENE

RENEURON GROUP PLC ORD 1P

TitleTime
CTX cell line shows further potentialThu 07/05/20 | 07:00
Second Price Monitoring ExtnTue 07/04/20 | 14:06
Price Monitoring ExtensionTue 07/04/20 | 14:00
Second Price Monitoring ExtnTue 07/04/20 | 11:06
Price Monitoring ExtensionTue 07/04/20 | 11:00
Exosome Research CollaborationTue 07/04/20 | 07:00
COVID-19 UpdateFri 03/04/20 | 07:00
Second Price Monitoring ExtnMon 16/03/20 | 16:43
Price Monitoring ExtensionMon 16/03/20 | 16:39
Block Listing Review and Total Voting RightsMon 02/03/20 | 07:00
Positive long-term data in retinal clinical trialMon 24/02/20 | 07:00
Positive Phase 2a stroke clinical data publishedMon 17/02/20 | 07:00
Notification of Major HoldingsWed 12/02/20 | 07:02
Notification of Major HoldingsWed 12/02/20 | 07:01
Notification of Major HoldingsWed 12/02/20 | 07:00
Notification of Major HoldingsFri 07/02/20 | 13:15
Notification of Major HoldingsThu 06/02/20 | 09:51
Total Voting RightsThu 02/01/20 | 07:00
Notification of Major HoldingsWed 18/12/19 | 12:10
NOTIFICATION OF MAJOR HOLDINGSMon 16/12/19 | 15:00
Interim ResultsFri 06/12/19 | 07:00
Notification of Interim ResultsMon 18/11/19 | 07:00
ReNeuron's lead cell line shows further potentialWed 23/10/19 | 07:00
Notification of Major HoldingsThu 17/10/19 | 17:36
Notification of Major HoldingsThu 17/10/19 | 15:21
Positive clinical data presented at AAO meetingMon 14/10/19 | 07:00
Second Price Monitoring ExtnWed 02/10/19 | 16:40
Price Monitoring ExtensionWed 02/10/19 | 16:35
Clinical Update and Conference PresentationsWed 02/10/19 | 07:00
Result of AGMThu 12/09/19 | 11:21
AGM Trading UpdateTue 10/09/19 | 07:00
Block Listing Review and TVRMon 02/09/19 | 07:00
Grant-funded collaboration with exosome platformWed 14/08/19 | 07:00
Posting of Annual Report and Notice of AGMFri 02/08/19 | 16:00
Notification of Major HoldingsFri 02/08/19 | 13:12
Total Voting RightsThu 01/08/19 | 11:50
Director/PDMR Interest in Shares & Share OptionsWed 17/07/19 | 07:00
Key patent grants expand exosome IP portfolioTue 16/07/19 | 07:00
Preliminary ResultsThu 11/07/19 | 07:00
Notification of Major HoldingsMon 08/07/19 | 16:30
Price Monitoring ExtensionMon 01/07/19 | 11:00
Total Voting RightsMon 01/07/19 | 07:00
Notification of Major HoldingsTue 18/06/19 | 16:01
Webcast of Preliminary ResultsTue 18/06/19 | 07:00
Total Voting RightsMon 03/06/19 | 07:00
Exercise of options, PDMR dealing and TVRThu 09/05/19 | 17:05
Year-end update and results notificationWed 08/05/19 | 07:00
Total Voting RightsThu 02/05/19 | 15:43
Second Price Monitoring ExtnFri 26/04/19 | 16:40
Price Monitoring ExtensionFri 26/04/19 | 16:35
Clinical update and conference presentationFri 26/04/19 | 07:00
Share Purchases by DirectorsThu 18/04/19 | 15:40
Exercise of Share Options and TVRFri 12/04/19 | 14:36
Share Purchases by DirectorsThu 11/04/19 | 16:31
Director/PDMR Shares and Share OptionsWed 10/04/19 | 14:37
ReNeuron partners with Fosun Pharma in ChinaTue 09/04/19 | 09:50
ReNeuron to present at UK investor conferenceFri 05/04/19 | 07:00
Clinical update and conference presentationThu 04/04/19 | 07:00
Second Price Monitoring ExtnThu 28/03/19 | 14:05
Price Monitoring ExtensionThu 28/03/19 | 14:00
Alliance for Regenerative Medicine presentationMon 18/03/19 | 12:00
Retinal clinical trial progresses to next stageMon 18/03/19 | 07:00
Notification of Major HoldingsTue 12/03/19 | 14:30
Notification of Major HoldingsTue 05/03/19 | 12:56
Notification of Major HoldingsTue 05/03/19 | 07:00
Notification of Major HoldingsTue 05/03/19 | 07:00
Block Listing Review and Total Voting RightsThu 28/02/19 | 07:00
Positive preliminary data in US retinal trialWed 20/02/19 | 07:00
New exosome production scale-up data presentedThu 31/01/19 | 07:00
First patient treated in US stroke trialThu 24/01/19 | 07:00
ReNeuron signs exosome collaborationFri 04/01/19 | 07:00
Interim ResultsFri 14/12/18 | 07:00
Notification of Interim ResultsTue 20/11/18 | 14:00
ReNeuron's lead cell line shows further potentialThu 18/10/18 | 07:00
Director/PDMR Interest in Shares and Share OptionsFri 28/09/18 | 14:16
Directors Share PurchasesThu 27/09/18 | 15:02
Second Price Monitoring ExtnWed 19/09/18 | 16:40
Price Monitoring ExtensionWed 19/09/18 | 16:35
Business development updateWed 19/09/18 | 07:00
Result of AGMWed 12/09/18 | 11:40
AGM Trading UpdateWed 12/09/18 | 07:00
Block Listing Review and TVRFri 31/08/18 | 07:00
Posting of Annual Report & Notice of AGMTue 31/07/18 | 15:25
Notification of Major HoldingsTue 17/07/18 | 07:00
Notification of Major HoldingsMon 16/07/18 | 15:39
Notification of Major HoldingsMon 16/07/18 | 07:00
Notification of Major HoldingsFri 13/07/18 | 11:50
Preliminary ResultsThu 12/07/18 | 07:00
Signs retinal stem cell exclusivity agreementWed 11/07/18 | 07:00
Notification of Preliminary ResultsWed 04/07/18 | 14:15
Capital Markets EventThu 17/05/18 | 07:00
Exosome data presented at ISCT conferenceFri 04/05/18 | 07:00
Capital Markets Event and WebcastMon 30/04/18 | 07:00
Wins grant for retinal cell therapy developmentThu 19/04/18 | 07:00
Appointment of US-based Chief Medical OfficerTue 10/04/18 | 13:00
Product Development UpdateMon 26/03/18 | 07:00
Block Listing Review and TVRThu 01/03/18 | 07:00
Block Listing ApplicationFri 16/02/18 | 07:00
Positive pre-clinical data in nerve injuryTue 13/02/18 | 10:00
Approval of Share Capital ReorganisationTue 23/01/18 | 11:06
Further re Share Capital ReorganisationThu 11/01/18 | 07:00
Proposed Share Capital ReorganisationFri 05/01/18 | 07:00
Interim resultsThu 14/12/17 | 07:00
Stroke clinical trial regulatory approval in USThu 14/12/17 | 07:00
ReNeuron opens US officeFri 08/12/17 | 07:00
Notification of Interim ResultsMon 13/11/17 | 11:30
Retinal disease clinical trial moves into Phase IIWed 08/11/17 | 07:00
Positive stroke clinical data & regulatory updateTue 31/10/17 | 07:00
Wins further UK grantFri 27/10/17 | 07:00
PDMR Interest in Shares and Share OptionsWed 11/10/17 | 13:31
Presentation of positive pre-clinical dataMon 09/10/17 | 07:00
Directors' Interest in Shares and Share OptionsTue 12/09/17 | 07:00
Result of AGMWed 06/09/17 | 11:15
AGM Trading UpdateWed 06/09/17 | 07:00
Non-executive Director AppointmentFri 01/09/17 | 07:00
Block Listing Review and TVRFri 01/09/17 | 07:00
Posting of Annual Report and Notice of AGMMon 07/08/17 | 15:04
Second Price Monitoring ExtnFri 04/08/17 | 16:40
Price Monitoring ExtensionFri 04/08/17 | 16:35
Appointment of joint brokerTue 25/07/17 | 07:00
Board changeWed 19/07/17 | 07:00
Preliminary ResultsThu 29/06/17 | 07:00
FDA approves cryopreserved hRPC formulationMon 19/06/17 | 07:00